Research investment strategy

Research Investment Strategy

We are actively inviting proposals dealing with all forms of meningitis and associated infections, improving prevention, treatment and outlook for patients, and improving the speed and accuracy of diagnosis.

Our Scientific Advisory Panel and Trustees are currently highlighting the following topics:

Research pertinent to prevention of bacterial meningitis and to maximising vaccine impact, including studies to:
 
  • evaluate vaccines or enable their evaluation
  • understand their mode of action
Research leading to prevention of neonatal meningitis and sepsis, including research which facilitates GBS vaccine development and implementation

Research in Africa that seeks to improve outcomes from meningitis by:

  • overcoming barriers to health seeking behaviour
  • improving prevention, treatment or health systems
  • improving recognition and accelerating the development and evaluation of rapid diagnostic tests (RDTs) for meningitis

We are particularly interested in projects that lead to practical interventions and partnerships in Africa.

In setting priority topics, our aim is to elicit strong, well-constructed research proposals on subjects we believe will have the most impact in terms of clinical/public health benefit or unlocking key research questions that will enable further translational research. We will consider funding basic science, but this must increase understanding of the disease area and have a clearly defined potential for early translation into alleviation of the diseases. Research funded must be of the highest scientific merit, in terms of the importance of the investigation, excellence of the study, ability of the research team, and probability of success.
Share this

Where next?

The stories that inspire us to create a world free from meningitis and septicaemia
Meningitis and septicaemia are serious, life threatening illnesses

Ways you can help

Please do what you can today and help save and change the lives of thousands